The global market for Desloratadine API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Desloratadine API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Desloratadine API by region & country, by Type, and by Application.
The Desloratadine API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Desloratadine API.
Market Segmentation
By Company
MOREPEN LABORATORIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD
LUPIN LTD
ORBION PHARMACEUTICALS PRIVATE LTD
GLENMARK LIFE SCIENCES LTD
DR REDDYS LABORATORIES LTD
CADILA PHARMACEUTICALS LTD
MYLAN LABORATORIES LTD
TARO PHARMACEUTICAL INDUSTRIES LTD
VASUDHA PHARMA CHEM LTD
HETERO LABS
CIPLA
ROLABO OUTSOURCING
HAINAN POLY PHARMACEUTICAL COMPANY
Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical
Venturepharm Pharmaceuticals锛坔ainan锛�
Zhejiang Huahai Pharmaceutical
Segment by Type:
笔耻谤颈迟测鈮�99%
Purity<99%
Segment by Application
Tablet
Oral Solution
Syrup
Capsule
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Desloratadine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Desloratadine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Desloratadine API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Desloratadine API Product Introduction
1.2 Global Desloratadine API Market Size Forecast
1.2.1 Global Desloratadine API Sales Value (2019-2030)
1.2.2 Global Desloratadine API Sales Volume (2019-2030)
1.2.3 Global Desloratadine API Sales Price (2019-2030)
1.3 Desloratadine API Market Trends & Drivers
1.3.1 Desloratadine API Industry Trends
1.3.2 Desloratadine API Market Drivers & Opportunity
1.3.3 Desloratadine API Market Challenges
1.3.4 Desloratadine API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Desloratadine API Players Revenue Ranking (2023)
2.2 Global Desloratadine API Revenue by Company (2019-2024)
2.3 Global Desloratadine API Players Sales Volume Ranking (2023)
2.4 Global Desloratadine API Sales Volume by Company Players (2019-2024)
2.5 Global Desloratadine API Average Price by Company (2019-2024)
2.6 Key Manufacturers Desloratadine API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Desloratadine API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Desloratadine API
2.9 Desloratadine API Market Competitive Analysis
2.9.1 Desloratadine API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Desloratadine API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Desloratadine API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 笔耻谤颈迟测鈮�99%
3.1.2 Purity<99%
3.2 Global Desloratadine API Sales Value by Type
3.2.1 Global Desloratadine API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Desloratadine API Sales Value, by Type (2019-2030)
3.2.3 Global Desloratadine API Sales Value, by Type (%) (2019-2030)
3.3 Global Desloratadine API Sales Volume by Type
3.3.1 Global Desloratadine API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Desloratadine API Sales Volume, by Type (2019-2030)
3.3.3 Global Desloratadine API Sales Volume, by Type (%) (2019-2030)
3.4 Global Desloratadine API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablet
4.1.2 Oral Solution
4.1.3 Syrup
4.1.4 Capsule
4.1.5 Others
4.2 Global Desloratadine API Sales Value by Application
4.2.1 Global Desloratadine API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Desloratadine API Sales Value, by Application (2019-2030)
4.2.3 Global Desloratadine API Sales Value, by Application (%) (2019-2030)
4.3 Global Desloratadine API Sales Volume by Application
4.3.1 Global Desloratadine API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Desloratadine API Sales Volume, by Application (2019-2030)
4.3.3 Global Desloratadine API Sales Volume, by Application (%) (2019-2030)
4.4 Global Desloratadine API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Desloratadine API Sales Value by Region
5.1.1 Global Desloratadine API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Desloratadine API Sales Value by Region (2019-2024)
5.1.3 Global Desloratadine API Sales Value by Region (2025-2030)
5.1.4 Global Desloratadine API Sales Value by Region (%), (2019-2030)
5.2 Global Desloratadine API Sales Volume by Region
5.2.1 Global Desloratadine API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Desloratadine API Sales Volume by Region (2019-2024)
5.2.3 Global Desloratadine API Sales Volume by Region (2025-2030)
5.2.4 Global Desloratadine API Sales Volume by Region (%), (2019-2030)
5.3 Global Desloratadine API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Desloratadine API Sales Value, 2019-2030
5.4.2 North America Desloratadine API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Desloratadine API Sales Value, 2019-2030
5.5.2 Europe Desloratadine API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Desloratadine API Sales Value, 2019-2030
5.6.2 Asia Pacific Desloratadine API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Desloratadine API Sales Value, 2019-2030
5.7.2 South America Desloratadine API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Desloratadine API Sales Value, 2019-2030
5.8.2 Middle East & Africa Desloratadine API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Desloratadine API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Desloratadine API Sales Value
6.2.1 Key Countries/Regions Desloratadine API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Desloratadine API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Desloratadine API Sales Value, 2019-2030
6.3.2 United States Desloratadine API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Desloratadine API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Desloratadine API Sales Value, 2019-2030
6.4.2 Europe Desloratadine API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Desloratadine API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Desloratadine API Sales Value, 2019-2030
6.5.2 China Desloratadine API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Desloratadine API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Desloratadine API Sales Value, 2019-2030
6.6.2 Japan Desloratadine API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Desloratadine API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Desloratadine API Sales Value, 2019-2030
6.7.2 South Korea Desloratadine API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Desloratadine API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Desloratadine API Sales Value, 2019-2030
6.8.2 Southeast Asia Desloratadine API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Desloratadine API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Desloratadine API Sales Value, 2019-2030
6.9.2 India Desloratadine API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Desloratadine API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 MOREPEN LABORATORIES LTD
7.1.1 MOREPEN LABORATORIES LTD Company Information
7.1.2 MOREPEN LABORATORIES LTD Introduction and Business Overview
7.1.3 MOREPEN LABORATORIES LTD Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 MOREPEN LABORATORIES LTD Desloratadine API Product Offerings
7.1.5 MOREPEN LABORATORIES LTD Recent Development
7.2 SUN PHARMACEUTICAL INDUSTRIES LTD
7.2.1 SUN PHARMACEUTICAL INDUSTRIES LTD Company Information
7.2.2 SUN PHARMACEUTICAL INDUSTRIES LTD Introduction and Business Overview
7.2.3 SUN PHARMACEUTICAL INDUSTRIES LTD Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 SUN PHARMACEUTICAL INDUSTRIES LTD Desloratadine API Product Offerings
7.2.5 SUN PHARMACEUTICAL INDUSTRIES LTD Recent Development
7.3 LUPIN LTD
7.3.1 LUPIN LTD Company Information
7.3.2 LUPIN LTD Introduction and Business Overview
7.3.3 LUPIN LTD Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 LUPIN LTD Desloratadine API Product Offerings
7.3.5 LUPIN LTD Recent Development
7.4 ORBION PHARMACEUTICALS PRIVATE LTD
7.4.1 ORBION PHARMACEUTICALS PRIVATE LTD Company Information
7.4.2 ORBION PHARMACEUTICALS PRIVATE LTD Introduction and Business Overview
7.4.3 ORBION PHARMACEUTICALS PRIVATE LTD Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 ORBION PHARMACEUTICALS PRIVATE LTD Desloratadine API Product Offerings
7.4.5 ORBION PHARMACEUTICALS PRIVATE LTD Recent Development
7.5 GLENMARK LIFE SCIENCES LTD
7.5.1 GLENMARK LIFE SCIENCES LTD Company Information
7.5.2 GLENMARK LIFE SCIENCES LTD Introduction and Business Overview
7.5.3 GLENMARK LIFE SCIENCES LTD Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.5.4 GLENMARK LIFE SCIENCES LTD Desloratadine API Product Offerings
7.5.5 GLENMARK LIFE SCIENCES LTD Recent Development
7.6 DR REDDYS LABORATORIES LTD
7.6.1 DR REDDYS LABORATORIES LTD Company Information
7.6.2 DR REDDYS LABORATORIES LTD Introduction and Business Overview
7.6.3 DR REDDYS LABORATORIES LTD Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.6.4 DR REDDYS LABORATORIES LTD Desloratadine API Product Offerings
7.6.5 DR REDDYS LABORATORIES LTD Recent Development
7.7 CADILA PHARMACEUTICALS LTD
7.7.1 CADILA PHARMACEUTICALS LTD Company Information
7.7.2 CADILA PHARMACEUTICALS LTD Introduction and Business Overview
7.7.3 CADILA PHARMACEUTICALS LTD Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.7.4 CADILA PHARMACEUTICALS LTD Desloratadine API Product Offerings
7.7.5 CADILA PHARMACEUTICALS LTD Recent Development
7.8 MYLAN LABORATORIES LTD
7.8.1 MYLAN LABORATORIES LTD Company Information
7.8.2 MYLAN LABORATORIES LTD Introduction and Business Overview
7.8.3 MYLAN LABORATORIES LTD Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.8.4 MYLAN LABORATORIES LTD Desloratadine API Product Offerings
7.8.5 MYLAN LABORATORIES LTD Recent Development
7.9 TARO PHARMACEUTICAL INDUSTRIES LTD
7.9.1 TARO PHARMACEUTICAL INDUSTRIES LTD Company Information
7.9.2 TARO PHARMACEUTICAL INDUSTRIES LTD Introduction and Business Overview
7.9.3 TARO PHARMACEUTICAL INDUSTRIES LTD Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.9.4 TARO PHARMACEUTICAL INDUSTRIES LTD Desloratadine API Product Offerings
7.9.5 TARO PHARMACEUTICAL INDUSTRIES LTD Recent Development
7.10 VASUDHA PHARMA CHEM LTD
7.10.1 VASUDHA PHARMA CHEM LTD Company Information
7.10.2 VASUDHA PHARMA CHEM LTD Introduction and Business Overview
7.10.3 VASUDHA PHARMA CHEM LTD Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.10.4 VASUDHA PHARMA CHEM LTD Desloratadine API Product Offerings
7.10.5 VASUDHA PHARMA CHEM LTD Recent Development
7.11 HETERO LABS
7.11.1 HETERO LABS Company Information
7.11.2 HETERO LABS Introduction and Business Overview
7.11.3 HETERO LABS Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.11.4 HETERO LABS Desloratadine API Product Offerings
7.11.5 HETERO LABS Recent Development
7.12 CIPLA
7.12.1 CIPLA Company Information
7.12.2 CIPLA Introduction and Business Overview
7.12.3 CIPLA Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.12.4 CIPLA Desloratadine API Product Offerings
7.12.5 CIPLA Recent Development
7.13 ROLABO OUTSOURCING
7.13.1 ROLABO OUTSOURCING Company Information
7.13.2 ROLABO OUTSOURCING Introduction and Business Overview
7.13.3 ROLABO OUTSOURCING Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.13.4 ROLABO OUTSOURCING Desloratadine API Product Offerings
7.13.5 ROLABO OUTSOURCING Recent Development
7.14 HAINAN POLY PHARMACEUTICAL COMPANY
7.14.1 HAINAN POLY PHARMACEUTICAL COMPANY Company Information
7.14.2 HAINAN POLY PHARMACEUTICAL COMPANY Introduction and Business Overview
7.14.3 HAINAN POLY PHARMACEUTICAL COMPANY Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.14.4 HAINAN POLY PHARMACEUTICAL COMPANY Desloratadine API Product Offerings
7.14.5 HAINAN POLY PHARMACEUTICAL COMPANY Recent Development
7.15 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical
7.15.1 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Company Information
7.15.2 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Introduction and Business Overview
7.15.3 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Desloratadine API Product Offerings
7.15.5 Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Recent Development
7.16 Venturepharm Pharmaceuticals锛坔ainan锛�
7.16.1 Venturepharm Pharmaceuticals锛坔ainan锛� Company Information
7.16.2 Venturepharm Pharmaceuticals锛坔ainan锛� Introduction and Business Overview
7.16.3 Venturepharm Pharmaceuticals锛坔ainan锛� Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Venturepharm Pharmaceuticals锛坔ainan锛� Desloratadine API Product Offerings
7.16.5 Venturepharm Pharmaceuticals锛坔ainan锛� Recent Development
7.17 Zhejiang Huahai Pharmaceutical
7.17.1 Zhejiang Huahai Pharmaceutical Company Information
7.17.2 Zhejiang Huahai Pharmaceutical Introduction and Business Overview
7.17.3 Zhejiang Huahai Pharmaceutical Desloratadine API Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Zhejiang Huahai Pharmaceutical Desloratadine API Product Offerings
7.17.5 Zhejiang Huahai Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Desloratadine API Industrial Chain
8.2 Desloratadine API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Desloratadine API Sales Model
8.5.2 Sales Channel
8.5.3 Desloratadine API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
MOREPEN LABORATORIES LTD
SUN PHARMACEUTICAL INDUSTRIES LTD
LUPIN LTD
ORBION PHARMACEUTICALS PRIVATE LTD
GLENMARK LIFE SCIENCES LTD
DR REDDYS LABORATORIES LTD
CADILA PHARMACEUTICALS LTD
MYLAN LABORATORIES LTD
TARO PHARMACEUTICAL INDUSTRIES LTD
VASUDHA PHARMA CHEM LTD
HETERO LABS
CIPLA
ROLABO OUTSOURCING
HAINAN POLY PHARMACEUTICAL COMPANY
Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical
Venturepharm Pharmaceuticals锛坔ainan锛�
Zhejiang Huahai Pharmaceutical
听
听
*If Applicable.
